Michael Petusky
Stock Analyst at Barrington Research
(2.20)
# 2,947
Out of 5,041 analysts
209
Total ratings
38.92%
Success rate
-2.51%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| USPH U.S. Physical Therapy | Maintains: Outperform | $103 | $93.16 | +10.56% | 25 | Oct 24, 2025 | |
| OFIX Orthofix Medical | Maintains: Outperform | $17 | $15.97 | +6.45% | 3 | Oct 23, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $78 | $63.84 | +22.18% | 17 | Oct 22, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $86 | $51.26 | +67.77% | 32 | Oct 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $95 | $89.21 | +6.49% | 13 | Oct 15, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $103 | $82.74 | +24.49% | 23 | Oct 7, 2025 | |
| OPCH Option Care Health | Maintains: Outperform | $38 | $27.91 | +36.15% | 17 | Sep 23, 2025 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $15 | $10.01 | +49.85% | 19 | Sep 23, 2025 | |
| VRME VerifyMe | Maintains: Outperform | $1.25 → $1.5 | $1.11 | +35.14% | 10 | Aug 14, 2025 | |
| SRDX Surmodics | Reiterates: Market Perform | n/a | $27.26 | - | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $21 → $18 | $13.11 | +37.30% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $2.25 | $1.50 | +50.00% | 14 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $6.76 | - | 6 | Aug 28, 2024 |
U.S. Physical Therapy
Oct 24, 2025
Maintains: Outperform
Price Target: $103
Current: $93.16
Upside: +10.56%
Orthofix Medical
Oct 23, 2025
Maintains: Outperform
Price Target: $17
Current: $15.97
Upside: +6.45%
Henry Schein
Oct 22, 2025
Maintains: Outperform
Price Target: $78
Current: $63.84
Upside: +22.18%
Haemonetics
Oct 21, 2025
Maintains: Outperform
Price Target: $86
Current: $51.26
Upside: +67.77%
LeMaitre Vascular
Oct 15, 2025
Maintains: Outperform
Price Target: $95
Current: $89.21
Upside: +6.49%
Merit Medical Systems
Oct 7, 2025
Maintains: Outperform
Price Target: $103
Current: $82.74
Upside: +24.49%
Option Care Health
Sep 23, 2025
Maintains: Outperform
Price Target: $38
Current: $27.91
Upside: +36.15%
Anika Therapeutics
Sep 23, 2025
Maintains: Outperform
Price Target: $15
Current: $10.01
Upside: +49.85%
VerifyMe
Aug 14, 2025
Maintains: Outperform
Price Target: $1.25 → $1.5
Current: $1.11
Upside: +35.14%
Surmodics
Aug 11, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $27.26
Upside: -
Aug 8, 2025
Maintains: Outperform
Price Target: $21 → $18
Current: $13.11
Upside: +37.30%
May 1, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.50
Upside: +50.00%
Aug 28, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $6.76
Upside: -